StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2022, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 22 Dec 2022 08:00:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Armata Pharmaceuticals Announces Completion of its Phase 1b/2a 'SWARM-P.a.' Study of Inhaled AP-PA02 in Cystic Fibrosis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html for the full story. http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html Thu, 22 Dec 2022 08:00:00 -0500 A.15221629 APHB ARMP O.00047144 O.00168871 Armata Pharmaceuticals Announces Completion of its Phase 1b/2a 'SWARM-P.a.' Study of Inhaled AP-PA02 in Cystic Fibrosis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html for the full story. http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html Thu, 22 Dec 2022 08:00:00 -0500 A.15221629 APHB ARMP O.00047144 O.00168871 Armata Pharmaceuticals Announces Completion of its Phase 1b/2a 'SWARM-P.a.' Study of Inhaled AP-PA02 in Cystic Fibrosis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html for the full story. http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html Thu, 22 Dec 2022 08:00:00 -0500 A.15221629 APHB ARMP O.00047144 O.00168871 Armata Pharmaceuticals Announces Completion of its Phase 1b/2a 'SWARM-P.a.' Study of Inhaled AP-PA02 in Cystic Fibrosis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html for the full story. http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html Thu, 22 Dec 2022 08:00:00 -0500 A.15221629 APHB ARMP O.00047144 O.00168871 Armata Pharmaceuticals Announces Completion of its Phase 1b/2a 'SWARM-P.a.' Study of Inhaled AP-PA02 in Cystic Fibrosis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html for the full story. http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html Thu, 22 Dec 2022 08:00:00 -0500 A.15221629 APHB ARMP O.00047144 O.00168871 Armata Pharmaceuticals Announces Completion of its Phase 1b/2a 'SWARM-P.a.' Study of Inhaled AP-PA02 in Cystic Fibrosis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html for the full story. http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html Thu, 22 Dec 2022 08:00:00 -0500 A.15221629 APHB ARMP O.00047144 O.00168871 Armata Pharmaceuticals Announces Completion of its Phase 1b/2a 'SWARM-P.a.' Study of Inhaled AP-PA02 in Cystic Fibrosis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html for the full story. http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html Thu, 22 Dec 2022 08:00:00 -0500 A.15221629 APHB ARMP O.00047144 O.00168871 Armata Pharmaceuticals Announces Completion of its Phase 1b/2a 'SWARM-P.a.' Study of Inhaled AP-PA02 in Cystic Fibrosis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html for the full story. http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html Thu, 22 Dec 2022 08:00:00 -0500 A.15221629 APHB ARMP O.00047144 O.00168871 Armata Pharmaceuticals Announces Completion of its Phase 1b/2a 'SWARM-P.a.' Study of Inhaled AP-PA02 in Cystic Fibrosis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html for the full story. http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html Thu, 22 Dec 2022 08:00:00 -0500 A.15221629 APHB ARMP O.00047144 O.00168871 Armata Pharmaceuticals Announces Completion of its Phase 1b/2a 'SWARM-P.a.' Study of Inhaled AP-PA02 in Cystic Fibrosis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html for the full story. http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+Announces+Completion+of+its+Phase+1b2a+%27SWARM-P.a.%27+Study+of+Inhaled+AP-PA02+in+Cystic+Fibrosis+Subjects+with+Chronic+Pulmonary+Pseudomonas+aeruginosa+Infection/20998603.html Thu, 22 Dec 2022 08:00:00 -0500 A.15221629 APHB ARMP O.00047144 O.00168871 Armata Pharmaceuticals to Participate in the H.C. Wainwright 1st Annual Investor Conference on Bacteriophage http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+1st+Annual+Investor+Conference+on+Bacteriophage/20899362.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+1st+Annual+Investor+Conference+on+Bacteriophage/20899362.html for the full story. http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+1st+Annual+Investor+Conference+on+Bacteriophage/20899362.html Mon, 28 Nov 2022 08:00:00 -0500 APHB ARMP O.00168871 Armata Pharmaceuticals to Participate in the H.C. Wainwright 1st Annual Investor Conference on Bacteriophage http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+1st+Annual+Investor+Conference+on+Bacteriophage/20899362.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+1st+Annual+Investor+Conference+on+Bacteriophage/20899362.html for the full story. http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+1st+Annual+Investor+Conference+on+Bacteriophage/20899362.html Mon, 28 Nov 2022 08:00:00 -0500 APHB ARMP O.00168871 Armata Pharmaceuticals to Participate in the H.C. Wainwright 1st Annual Investor Conference on Bacteriophage http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+1st+Annual+Investor+Conference+on+Bacteriophage/20899362.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+1st+Annual+Investor+Conference+on+Bacteriophage/20899362.html for the full story. http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+1st+Annual+Investor+Conference+on+Bacteriophage/20899362.html Mon, 28 Nov 2022 08:00:00 -0500 APHB ARMP O.00168871 Armata Pharmaceuticals to Participate in the H.C. Wainwright 1st Annual Investor Conference on Bacteriophage http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+1st+Annual+Investor+Conference+on+Bacteriophage/20899362.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+1st+Annual+Investor+Conference+on+Bacteriophage/20899362.html for the full story. http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+1st+Annual+Investor+Conference+on+Bacteriophage/20899362.html Mon, 28 Nov 2022 08:00:00 -0500 APHB ARMP O.00168871 Armata Pharmaceuticals to Participate in the H.C. Wainwright 1st Annual Investor Conference on Bacteriophage http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+1st+Annual+Investor+Conference+on+Bacteriophage/20899362.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+1st+Annual+Investor+Conference+on+Bacteriophage/20899362.html for the full story. http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+1st+Annual+Investor+Conference+on+Bacteriophage/20899362.html Mon, 28 Nov 2022 08:00:00 -0500 APHB ARMP O.00168871 Armata Pharmaceuticals to Participate in the H.C. Wainwright 1st Annual Investor Conference on Bacteriophage http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+1st+Annual+Investor+Conference+on+Bacteriophage/20899362.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+1st+Annual+Investor+Conference+on+Bacteriophage/20899362.html for the full story. http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+to+Participate+in+the+H.C.+Wainwright+1st+Annual+Investor+Conference+on+Bacteriophage/20899362.html Mon, 28 Nov 2022 08:00:00 -0500 APHB ARMP O.00168871 Armata Pharmaceuticals Provides Update on Pseudomonas Respiratory Programs http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+Provides+Update+on+Pseudomonas+Respiratory+Programs/19422401.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+Provides+Update+on+Pseudomonas+Respiratory+Programs/19422401.html for the full story. http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+Provides+Update+on+Pseudomonas+Respiratory+Programs/19422401.html Wed, 05 Jan 2022 08:00:00 -0500 APHB ARMP Armata Pharmaceuticals Provides Update on Pseudomonas Respiratory Programs http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+Provides+Update+on+Pseudomonas+Respiratory+Programs/19422401.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+Provides+Update+on+Pseudomonas+Respiratory+Programs/19422401.html for the full story. http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+Provides+Update+on+Pseudomonas+Respiratory+Programs/19422401.html Wed, 05 Jan 2022 08:00:00 -0500 APHB ARMP Armata Pharmaceuticals Provides Update on Pseudomonas Respiratory Programs http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+Provides+Update+on+Pseudomonas+Respiratory+Programs/19422401.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+Provides+Update+on+Pseudomonas+Respiratory+Programs/19422401.html for the full story. http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+Provides+Update+on+Pseudomonas+Respiratory+Programs/19422401.html Wed, 05 Jan 2022 08:00:00 -0500 APHB ARMP Armata Pharmaceuticals Provides Update on Pseudomonas Respiratory Programs http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+Provides+Update+on+Pseudomonas+Respiratory+Programs/19422401.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+Provides+Update+on+Pseudomonas+Respiratory+Programs/19422401.html for the full story. http://www.streetinsider.com/PRNewswire/Armata+Pharmaceuticals+Provides+Update+on+Pseudomonas+Respiratory+Programs/19422401.html Wed, 05 Jan 2022 08:00:00 -0500 APHB ARMP Armata Pharma (ARMP) Provides Regulatory and Clinical Update Reflecting Sustained Progress Across Key Phage Therapeutic Development Programs http://www.streetinsider.com/Corporate+News/Armata+Pharma+%28ARMP%29+Provides+Regulatory+and+Clinical+Update+Reflecting+Sustained+Progress+Across+Key+Phage+Therapeutic+Development+Programs/19238683.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Armata+Pharma+%28ARMP%29+Provides+Regulatory+and+Clinical+Update+Reflecting+Sustained+Progress+Across+Key+Phage+Therapeutic+Development+Programs/19238683.html for the full story. http://www.streetinsider.com/Corporate+News/Armata+Pharma+%28ARMP%29+Provides+Regulatory+and+Clinical+Update+Reflecting+Sustained+Progress+Across+Key+Phage+Therapeutic+Development+Programs/19238683.html Thu, 18 Nov 2021 08:10:25 -0500 APHB ARMP Armata Pharma (ARMP) Provides Regulatory and Clinical Update Reflecting Sustained Progress Across Key Phage Therapeutic Development Programs http://www.streetinsider.com/Corporate+News/Armata+Pharma+%28ARMP%29+Provides+Regulatory+and+Clinical+Update+Reflecting+Sustained+Progress+Across+Key+Phage+Therapeutic+Development+Programs/19238683.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Armata+Pharma+%28ARMP%29+Provides+Regulatory+and+Clinical+Update+Reflecting+Sustained+Progress+Across+Key+Phage+Therapeutic+Development+Programs/19238683.html for the full story. http://www.streetinsider.com/Corporate+News/Armata+Pharma+%28ARMP%29+Provides+Regulatory+and+Clinical+Update+Reflecting+Sustained+Progress+Across+Key+Phage+Therapeutic+Development+Programs/19238683.html Thu, 18 Nov 2021 08:10:25 -0500 APHB ARMP Armata Pharma (ARMP) Provides Regulatory and Clinical Update Reflecting Sustained Progress Across Key Phage Therapeutic Development Programs http://www.streetinsider.com/FDA/Armata+Pharma+%28ARMP%29+Provides+Regulatory+and+Clinical+Update+Reflecting+Sustained+Progress+Across+Key+Phage+Therapeutic+Development+Programs/19238683.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/Armata+Pharma+%28ARMP%29+Provides+Regulatory+and+Clinical+Update+Reflecting+Sustained+Progress+Across+Key+Phage+Therapeutic+Development+Programs/19238683.html for the full story. http://www.streetinsider.com/FDA/Armata+Pharma+%28ARMP%29+Provides+Regulatory+and+Clinical+Update+Reflecting+Sustained+Progress+Across+Key+Phage+Therapeutic+Development+Programs/19238683.html Thu, 18 Nov 2021 08:10:25 -0500 APHB ARMP Armata Pharma (ARMP) Provides Regulatory and Clinical Update Reflecting Sustained Progress Across Key Phage Therapeutic Development Programs http://www.streetinsider.com/FDA/Armata+Pharma+%28ARMP%29+Provides+Regulatory+and+Clinical+Update+Reflecting+Sustained+Progress+Across+Key+Phage+Therapeutic+Development+Programs/19238683.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/Armata+Pharma+%28ARMP%29+Provides+Regulatory+and+Clinical+Update+Reflecting+Sustained+Progress+Across+Key+Phage+Therapeutic+Development+Programs/19238683.html for the full story. http://www.streetinsider.com/FDA/Armata+Pharma+%28ARMP%29+Provides+Regulatory+and+Clinical+Update+Reflecting+Sustained+Progress+Across+Key+Phage+Therapeutic+Development+Programs/19238683.html Thu, 18 Nov 2021 08:10:25 -0500 APHB ARMP Armata Pharmaceuticals Provides Regulatory and Clinical Update Reflecting Sustained Progress Across Key Phage Therapeutic Development Programs http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+Provides+Regulatory+and+Clinical+Update+Reflecting+Sustained+Progress+Across+Key+Phage+Therapeutic+Development+Programs/19238517.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+Provides+Regulatory+and+Clinical+Update+Reflecting+Sustained+Progress+Across+Key+Phage+Therapeutic+Development+Programs/19238517.html for the full story. http://www.streetinsider.com/Press+Releases/Armata+Pharmaceuticals+Provides+Regulatory+and+Clinical+Update+Reflecting+Sustained+Progress+Across+Key+Phage+Therapeutic+Development+Programs/19238517.html Thu, 18 Nov 2021 08:00:00 -0500 A.06822034 A.09231922 A.40958841 APHB ARMP